Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study - Wikidata - awgldk - TriplyDB

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

http://www.wikidata.org/entity/Q27320151

about

Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs Access to Addiction Pharmacotherapy in Private Health Plans.Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia.Treatment of adult patients with schizophrenia and complex mental health needs - A national clinical guideline.Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial.A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal.Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.Guidelines for the Pharmacotherapy of Schizophrenia in Adults.Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients.Will the Proteus sensor enhance adherence to aripiprazole or other antipsychotics?Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data

P2860

Q28085407-008E7170-CED2-4600-9034-B782324B8AB3 Q36025907-10754CC0-C142-440B-BD6F-B0FDD0CC1C8A Q36798150-F5B368E2-9767-4736-B9E2-37C9420238E3 Q38578316-C17E5E49-B72E-4CE1-89F0-45CDF219C2F8 Q38625817-59359AC9-49C1-4A1F-8137-D52BEAD197AB Q38659006-9434AA1C-CB9C-466C-93A5-3684E23A30B0 Q38851847-6376ECE7-D34B-454F-873D-C4E92DBECC28 Q39432209-983689E3-2859-4B22-BD3D-041F79AAC1B7 Q41656775-6AD423AD-6C67-4726-94E8-759159107F11 Q42088414-27A07D41-016B-4677-9CCB-B64A064DFFE4 Q50598854-4E27D294-54B8-4189-B42F-4EB4406E1B8A Q58749200-EAAE8528-EBA6-44FD-90D8-7F20516CF414

P2860

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

http://www.wikidata.org/entity/Q27320151

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

@ast

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

@en

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

@nl

type

label

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

@ast

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

@en

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

@nl

prefLabel

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

@ast

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

@en

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

@nl

P1433

Q27320151-912114B2-B1B3-4DC3-84E2-AD92C3DC37F4

P1476

Q27320151-7EF47A34-1F4A-4CA4-843E-97E10110BB44

P2093

Q27320151-0719E15B-C6ED-4097-B646-FA51764BF6BF

Q27320151-1F09024D-4C25-4FBD-BDD9-1AA0C84D596E

Q27320151-31B94EC0-E8AC-4241-9465-DE9EB763B785

Q27320151-3EF3CFF7-1C63-4D61-9B26-13F409B4492D

Q27320151-45588EA9-3569-4B72-A824-DE1BAB331136

Q27320151-55A87A85-8522-4523-B2A0-7EDDC28B439A

Q27320151-73AD6175-2868-455F-B5BA-645DC1D21FA3

Q27320151-9A83706B-F3CB-4008-85DB-1A3C500400A3

Q27320151-9D07B5A8-EF92-4293-A64A-B81D96505905

Q27320151-A61EBB94-BDC3-4F11-BA89-0479B1E5E1D4

P2860

Q27320151-08BE4F09-E078-4EDC-A930-36BD604B44C6

Q27320151-1CE2E7F9-94FA-4D64-AE1F-E4D7B072A23E

Q27320151-226173C8-5B4A-4116-88CC-F1097BB6CDE4

Q27320151-4CA5799E-2166-487E-A080-372DB6ECA2FF

Q27320151-4EC3DA7B-12CF-4A66-9C31-6E2CECF84588

Q27320151-587838B3-19D3-4912-891E-4F1887AB1B72

Q27320151-63D0975D-FB80-4030-BFA5-F3B423EC9D95

Q27320151-65A6BF43-8003-4C11-AA0B-6D03924B3230

Q27320151-7093A914-4E22-414B-931C-93AC3F5CF0C6

Q27320151-72632CBB-9743-4B2B-863D-A41F05A3785A

P304

Q27320151-0B741264-0A3C-4C91-B94A-9DDED16733A3

P31

Q27320151-020CA897-3D0B-4E42-A5BB-29FA1D035A7F

P356

Q27320151-ABE5B111-BC16-402A-B88F-A601E987B299

P407

Q27320151-416267DE-9200-4C88-BABD-5D1704F0F02E

P433

Q27320151-352A29DF-B20D-496E-9ECB-FE3DE2BE6A28

P478

Q27320151-4B83070F-B207-4E80-B5FD-67FF549880EF

P50

Q27320151-1A19DBB3-3DF5-47C5-BF32-F3E2BC9A9252

Q27320151-2AB8C07E-E8A4-492D-9E4A-87550A311C50

Q27320151-DEA5A783-605E-488B-A5DE-074666A016DB

P577

Q27320151-7B0BEB43-E1F3-4F70-84B6-B74EE74B5ECE

P5875

Q27320151-A827C9F3-B00D-49EA-BEB7-122B301EB3E4

P698

Q27320151-2022D979-0D7E-47C0-B385-3456FC89D4BE

P932

Q27320151-C4193987-19C0-476F-A0B2-A969C9E52EFC

P356

P1433

Schizophrenia Bulletin

P1476

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

@en

P2093

Alan J Mendelowitz

http://www.w3.org/2001/XMLSchema#string

Alexander Kopelowicz

http://www.w3.org/2001/XMLSchema#string

Daniel R Wilson

http://www.w3.org/2001/XMLSchema#string

Donna Ames

http://www.w3.org/2001/XMLSchema#string

Jim Mintz

http://www.w3.org/2001/XMLSchema#string

Joanne B Severe

http://www.w3.org/2001/XMLSchema#string

John Hsiao

http://www.w3.org/2001/XMLSchema#string

John Lauriello

http://www.w3.org/2001/XMLSchema#string

John M Kane

http://www.w3.org/2001/XMLSchema#string

Juan Bustillo

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for drug-induced akathisia

Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials.

Negative symptoms in schizophrenia. Definition and reliability.

A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia

Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial.

Past and present progress in the pharmacologic treatment of schizophrenia.

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies.

A web-based program to empower patients who have schizophrenia to discuss quality of care with mental health providers.

Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics

P304

449-459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/SCHBUL/SBU067

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

Theo C Manschreck

P577

2014-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264934765

http://www.w3.org/2001/XMLSchema#string

P698

24870446

http://www.w3.org/2001/XMLSchema#string

P932

4332934

http://www.w3.org/2001/XMLSchema#string